Similarly, in Cambodia, Blanc, et al. found that patients with a CD4 count less than 200 cells/mm3 who started ART within 2 weeks of TB treatment initiation experienced significantly better survival rates than those who started ART 8 weeks after TB treatment initiation [54]. This evidence concerns the gene CD4 and tuberculosis.